Medline IPO Soars 41% After $6.3 Billion Offering, a Major Win for Private Equity

Medline Industries, a private equity-backed medical supply company, saw its stock surge by 41% in its Wall Street debut on Wednesday, following the completion of a $6.3 billion initial public offering (IPO). The offering was the largest of 2025, eclipsing the $5.4 billion Medline had originally anticipated and surpassing the $5.3 billion raised by CATL earlier in the year. Medline’s shares closed at $41, significantly above the initial price of $29 per share.